Ted M. Lakowski

university of manitoba

H指数:20

被引数:1,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines

蛋白酶体抑制剂硼替佐米对人白血病细胞系组蛋白修饰的影响

International Journal of Molecular Sciences

IF4.9

2026-07-260

OAAI

Dose dependent paradoxical increases in DNA methylation, reductions in p16 expression, and changes in histone modifications in gastric cancer cells treated with DNMT inhibitors

剂量依赖性的反常DNA甲基化增加、p16表达降低以及DNMT抑制剂处理的胃癌细胞中组蛋白修饰的改变

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2026-03-300

OAAI

Denaturation, rapid dilution refolding, and single-step purification of the core histones using desalting size-exclusion chromatography

变性、快速稀释复性和使用脱盐排阻色谱法对核心组蛋白进行单步纯化

Methods

IF4.3

2025-12-110

PRE

DNA intercalating drugs: Mechanisms of action in cancer treatment

DNA嵌入药物：癌症治疗中的作用机制

ADVANCES IN BIOLOGICAL REGULATION

IF0

2025-09-011

OAAI

SET7/9 exhibits sigmoidal kinetics on nucleosomes, hyperbolic kinetics on histones by an ordered sequential mechanism and methylates lysine and arginine

SET7/9在核小体上表现出S形动力学，在组蛋白上通过有序顺序机制表现出双曲线动力学，并甲基化赖氨酸和精氨酸。

Journal of Biological Chemistry

IF3.9

2025-08-280

OAAI

Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-090

OAAI

Extracellular macrophage migration inhibitory factor (MIF) downregulates adipose hormone-sensitive lipase (HSL) and contributes to obesity

MOLECULAR METABOLISM

IF6.6

2024-01-018

OAAI

Protein arginine N-methyltransferase 2 plays a noncatalytic role in the histone methylation activity of PRMT1

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2023-12-015

OAAI

Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets

CELLS

IF5.2

2022-09-109

OAAI

Predicting breast cancer drug response using a multiple-layer cell line drug response network model

BMC CANCER

IF3.4

2021-05-318

OAAI

SARS-CoV-2 multifaceted interaction with the human host. PartII: Innate immunity response, immunopathology, and epigenetics

SARS-CoV-2与人类宿主的多方面互动。部分: 先天免疫反应，免疫病理学和表观遗传学

IUBMB LIFE

IF3.2

2020-09-1630

OAAI

SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities

IUBMB LIFE

IF3.2

2020-09-129

PREAI

Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors

PHARMACEUTICS

IF5.5

2019-09-1715

OAAI

Antimicrobial Prophylaxis for Patients Undergoing Cardiac Surgery: Intraoperative Cefazolin Concentrations and Sternal Wound Infections Sheryl

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2018-11-0119

OAAI

Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes

JOURNAL OF PROTEOME RESEARCH

IF3.6

2018-07-0422

PREAI

Absolute Oral Bioavailability of Creatine Monohydrate in Rats: Debunking a Myth

PHARMACEUTICS

IF5.5

2018-03-0820

OAAI

Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2017-12-0816

OAAI

Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

JOURNAL OF PROTEOME RESEARCH

IF3.6

2017-11-2013

PREAI

Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids

PHARMACEUTICS

IF5.5

2017-10-1228

OAAI

Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs

口服多组分联合膳食补充剂的药代动力学分析 (Phycox®) 在狗中

PHARMACEUTICS

IF5.5

2017-08-187

OAAI

Ted M. Lakowski

个人简介

教育背景

工作经历

荣誉奖项

研究方向